Outset Medical (OM) Stock Forecast & Price Target

Outset Medical Inc. is poised for a favorable financial future due to its stability in the salesforce, an expanding product pipeline, and a robust recurring revenue model, alongside efforts to enhance margins. The company achieved a gross margin of 42.9%, exceeding market expectations, while maintaining guidance for continued improvement, positioning itself to reach a long-term gross margin goal of 50%. Additionally, with a targeted cash burn of less than $50 million by 2025 and ongoing initiatives for cost reduction and operational efficiencies, Outset Medical appears well-positioned for profitability and sustained growth in the medical technology sector.

Outset Medical has lowered its full-year revenue guidance by approximately $7 million, primarily due to delays in enterprise deal timing and weaker-than-expected Consumables sales, which account for a significant portion of total revenues. Despite solid Console revenue, the company reported total revenues of $29.4 million, falling short of both internal and consensus expectations, highlighting challenges with Consumable utilization that did not align with order volumes. Additionally, the 2026 revenue outlook of $125 million to $130 million reflects only modest growth, emphasizing the ongoing pressures that may negatively impact overall stock performance.